B
asal and shear-mediated blood flow is regulated in large part by nitric oxide (NO) produced by the endothelial NO synthase. This oxygen-and l-arginine-dependent process regulates 25% of resting blood flow and is further activated by the shear stress of exercise-induced metabolic vasodilation to enhance NO-dependent vasodilation of conduit vessels. 1 NO that is produced under basal conditions and enhanced by exercise shear-activated NO synthase not only vasodilates but also is oxidized in plasma to form nitrite and S-nitrosothiol compounds. 2 How these NO metabolites contribute to blood flow and endocrine NO signaling has been the subject of active research and debate over the last 15 years. 3 Two dominant theories have been proposed, both of which require red blood cell and deoxyhemoglobin-dependent bioactivation. The S-nitroso-hemoglobin (SNO-Hb) hypothesis posits that NO binds covalently to the conserved cysteine 93 residue of hemoglobin and during deoxygenation releases an intermediate (still not defined) that is exported from the red blood cell as a low-molecular-weight S-nitrosothiol, leading to hypoxic vasodilation. 4 The nitrite reductase hypothesis posits that the endocrine reservoir is nitrite, and during arterial-to-venous (A-V) transit, the nitrite reacts with the deoxyheme of hemoglobin to form NO (and N 2 O 3 ), which produces hypoxic vasodilation. 5, 6 The latter hypothesis has been supported by experimental data showing that other globins, including myoglobin, cytoglobin, neuroglobin, and globin X, signal via nitrite reduction. [7] [8] [9] This signaling has been shown to modulate hypoxic vasodilation, platelet activation, and mitochondrial respiration (recent platelet inhibition studies summarized by Corti et al 10 ). Both models propose allosteric-coupled hemoglobin deoxygenation and NO delivery, and both models have central mechanisms that are testable.
The study by Bailey and colleagues 11 in this issue of Circulation revisits the measurement of NO metabolites in the cerebral and leg arterial and venous circulation, in the plasma and red blood cells, at rest, during hypoxia, and during 2 levels of graded aerobic exercise. These physiological studies are well designed and assess gradients across 2 systemic circulatory beds, with 5-fold increases in blood flow during exercise. However, the study suffers from a number of limitations that are recognized by the investigators such as a sample size (only 7 volunteer subjects) and a lack of measurable increases in blood flow in the cerebral and leg circulation during the hypoxic challenge (no evident hypoxic vasodilation). These limitations notwithstanding and accepting the caveat that gradient analyses do not confirm mechanism, we can evaluate the results of this work and determine how well the data conform to predictions based on the 2 red cell-NO delivery hypotheses.
In brief summary, Bailey and colleagues observe significant gradients of nitrite with arterial levels greater than venous levels during rest. After systemic hypoxia, the arterial nitrite levels decrease to the level observed in the venous circulation. In
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Evidence for the Nitrite Hypothesis contrast, they do not observe significant A-V gradients of SNO-Hb; although not significant, the SNO-Hb levels increase in the venous circulation (V>A) under all conditions tested. During exercise, the arterial nitrite levels increase and the A-V gradients are preserved, with significant increases in the calculated nitrite consumption (using Fick estimates of consumption: blood flow times the A-V nitrite gradient). There is a very significant increase in red cell NO metabolite accumulation from A-V during hypoxia and especially exercise, with the dominant and only statistically significant species formed being iron-nitrosylated hemoglobin (NO bound to the heme of hemoglobin [Fe
+2
-NO]). The nitrite-reductase hypothesis was grounded in observations of A-V gradients in nitrite, with nitrite consumption from artery to vein (A>V) and a reaction in the red cell between nitrite and deoxyhemoglobin to form NO. 5 The NO would then bind to viscinal deoxyhemoglobins to form iron-nitrosylated hemoglobin (Fe Bailey et al observe robust A-V plasma nitrite gradients across the brain at rest (380 to 286 nmol/L) and across the leg at rest (380 to 320 nmol/L). The arterial levels of nitrite drop with hypoxia, as the hypothesis predicts, and exercise results in a significant increase in arterial nitrite production and consumption across both vascular beds (brain, 404 to 295 nmol/L; leg, 404 to 324 nmol/L). Shear activation of conduit vessel endothelial NO synthase will increase NO and nitrite production, consistent with higher arterial levels, and maintained A-V gradients indicate that nitrite is consumed during the metabolic stress of exercise. Note that the gradient is observed in the setting of a 5-fold increase in blood flow, indicating large increases in nitrite consumption, according to the Fick principle, similar to prior published studies of nitrite metabolism during forearm exercise. 12 Finally, red cell iron-nitrosylated hemoglobin (Fe +2 -NO) increases dramatically in all of these conditions, with Fe +2 -NO representing the largest and only significant contributor to the total observed red cell NO species formed. Fe +2 -NO levels increased significantly with hypoxia from artery to vein, with additional increases with exercise, again consistent with the nitrite reductase hypothesis (Equations 1 and 2 ). These observations are similar to those observed with nitrite infusions in humans, with consumption of nitrite across the circulation and metabolism to form venous Fe +2 -NO and, to a lesser extent, SNO in the red cell. 5 The SNO-Hb hypothesis was grounded on observations of A-V gradients in SNO-Hb in the red cell, with allosterically mediated release from A-V, resulting in a drop in SNO-Hb in the red cell and a rise in plasma S-nitrosothiols in the venous circulation. 4 The results here are the opposite, with no gradients observed in plasma or red blood SNO-Hb under any conditions. The red cell SNO-Hb measures are contrary to the hypothesis, with nonsignificant increases in the venous circulation rather than a decrease consistent with S-nitrosothiol delivery. There are nonsignificant drops in plasma SNO in the brain circulation, but these should go up if S-nitrosothiols are released from SNO-Hb during deoxygenation. However, the rise is not close to significant with high standard deviations (note that the A-V levels with exercise are 34±31 versus 41±20; n=7) and not consistent across all measured conditions and circulatory systems.
In conclusion, these measurements are consistent with consumption of nitrite in plasma from artery to vein, with enhanced nitrite consumption during exercise. Nitrite consumption is coupled to Fe +2 -NO formation in the red blood cell from artery to vein at rest, during hypoxemia, and especially during exercise. The nitrite consumption gradients and Fe +2 -NO formation gradients are the most statistically robust observations in these studies and conform to Equations 1 and 2. These gradients reproduce the original observations in the forearm circulation during exercise and nitrite infusions that informed the nitrite reductase hypothesis. 5, 12 Recent studies that other globins exhibit nitrite-reductase signaling activity, confirmed with genetic knockdown approaches, provide more direct evidence in support of this hypothesis. 
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